# Efficacy and Safety of Tocilizumab in Adult's Still Disease

> **NCT01002781** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Adult's Still Disease

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT01002781
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002781, "Efficacy and Safety of Tocilizumab in Adult's Still Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01002781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*